Deployment of convalescent plasma for the prevention and treatment of COVID-19Evan M. Bloch, Aaron A.R. Tobian, Shmuel Shoham et al.|Journal of Clinical Investigation|2020Cited by 863
Plasmodium falciparum resistant to artemisinin and diagnostics have emerged in EthiopiaAbebe A. Fola, Jeffrey A. Bailey, Sindew Mekasha Feleke et al.|Nature Microbiology|2023Cited by 190
Drug-Resistance and Population Structure of Plasmodium falciparum Across the Democratic Republic of Congo Using High-Throughput Molecular Inversion ProbesÖzkan Aydemir, Jeffrey A. Bailey, Mark Janko et al.|The Journal of Infectious Diseases|2018Cited by 147
Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistanceDeus S. Ishengoma, Marian Warsame, Celine I. Mandara et al.|The Lancet Infectious Diseases|2024Cited by 99
Country wide surveillance reveals prevalent artemisinin partial resistance mutations with evidence for multiple origins and expansion of high level sulfadoxine-pyrimethamine resistance mutations in northwest TanzaniaJonathan J. Juliano, Deus S. Ishengoma, Rashid A. Madebe et al.|medRxiv|2023Cited by 60